Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 6-7, Juin–Juillet 2012
Page(s) 625 - 632
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2012286016
Publié en ligne 16 juillet 2012
  1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005 ; 366 : 665–675. [CrossRef] [PubMed] [Google Scholar]
  2. Wallace MR, Marchuk DA, Andersen LB, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990 ; 249 : 181–186. [CrossRef] [PubMed] [Google Scholar]
  3. Mulligan LM, Kwok JB, Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993 ; 363 : 458–460. [CrossRef] [PubMed] [Google Scholar]
  4. Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994 ; 7 : 85–90. [CrossRef] [PubMed] [Google Scholar]
  5. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000 ; 287 : 848–851. [CrossRef] [PubMed] [Google Scholar]
  6. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000 ; 26 : 268–270. [CrossRef] [PubMed] [Google Scholar]
  7. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001 ; 69 : 49–54. [CrossRef] [PubMed] [Google Scholar]
  8. Dahia PL, Ross KN, Wright ME, et al. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 2005 ; 1 : 72–80. [CrossRef] [PubMed] [Google Scholar]
  9. Eisenhofer G, Huynh TT, Pacak K, et al. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocr Relat Cancer 2004 ; 11 : 897–911. [CrossRef] [PubMed] [Google Scholar]
  10. Lopez-Jimenez E, Gomez-Lopez G, Leandro-Garcia LJ, et al. Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas. Mol Endocrinol 2010 ; 24 : 2382–2391. [CrossRef] [PubMed] [Google Scholar]
  11. Burnichon N, Vescovo L, Amar L, et al. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum Mol Genet 2011 ; 20 : 3974–3985. [CrossRef] [PubMed] [Google Scholar]
  12. Favier J, Briere JJ, Burnichon N, et al. The warburg effect is genetically determined in inherited pheochromocytomas. PloS One 2009 ; 4 : e7094. [CrossRef] [PubMed] [Google Scholar]
  13. Qin Y, Yao L, King EE, et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 2010 ; 42 : 229–233. [CrossRef] [PubMed] [Google Scholar]
  14. Burnichon N, Briere JJ, Libe R, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010 ; 19 : 3011–3020. [CrossRef] [PubMed] [Google Scholar]
  15. Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F, et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 2011 ; 43 : 663–667. [CrossRef] [PubMed] [Google Scholar]
  16. Van Nederveen FH, Gaal J, Favier J, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 2009 ; 10 : 764–771. [CrossRef] [PubMed] [Google Scholar]
  17. Pouyssegur J, Gothie E. HIF-1 : régulateur central de l’hypoxie. Med Sci (Paris) 2002 ; 18 : 70–78. [CrossRef] [EDP Sciences] [Google Scholar]
  18. Favier J, Gimenez-Roqueplo AP. Pheochromocytomas: the (pseudo)-hypoxic hypothesis. Best Pract Res Clin Endocrinol Metab 2010 ; 24 : 957–968. [CrossRef] [PubMed] [Google Scholar]
  19. Favier J, Igaz P, Burnichon N, et al. Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma. Endocr Pathol 2011 ; 23 : 34–42. [CrossRef] [Google Scholar]
  20. Barontini M, Dahia PL. VHL disease. Best Pract Res Clin Endocrinol Metab 2010 ; 24 : 401–413. [CrossRef] [PubMed] [Google Scholar]
  21. Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002 ; 346 : 1459–1466. [CrossRef] [PubMed] [Google Scholar]
  22. Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American thyroid association. Thyroid 2009 ; 19 : 565–612. [CrossRef] [PubMed] [Google Scholar]
  23. Wolkenstein P. La neurofibromatose 1. Med Sci (Paris) 2001 ; 17 : 1158–1167. [CrossRef] [EDP Sciences] [Google Scholar]
  24. Bausch B, Koschker AC, Fassnacht M, et al. Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. J Clin Endocrinol Metab 2006 ; 91 : 3478–3481. [CrossRef] [PubMed] [Google Scholar]
  25. Korpershoek E, Favier J, Gaal J, et al. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab 2011 ; 96 : E1472–E1476. [CrossRef] [PubMed] [Google Scholar]
  26. Hao HX, Khalimonchuk O, Schraders M, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009 ; 325 : 1139–1142. [CrossRef] [PubMed] [Google Scholar]
  27. Bayley JP, Kunst HP, Cascon A, et al. SDHAF2 mutations in familial and sporadic paraganglioma and pheochromocytoma. Lancet Oncol 2010 ; 11 : 366–372. [CrossRef] [PubMed] [Google Scholar]
  28. Kunst HP, Rutten MH, de Monnink JP, et al. SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma. Clin Cancer Res 2011 ; 17 : 247–254. [CrossRef] [PubMed] [Google Scholar]
  29. Burnichon N, Lepoutre-Lussey C, Laffaire J, et al. A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma. Eur J Endocrinol 2011 ; 164 : 141–145. [CrossRef] [PubMed] [Google Scholar]
  30. Yao L, Schiavi F, Cascon A, et al. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA 2010 ; 304 : 2611–2619. [CrossRef] [PubMed] [Google Scholar]
  31. Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000 ; 16 : 653–699. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.